ARPA-H Emerging Health Innovators (EHI) Initiative
Solicitation from Department of Health and Human Services.
Data as of Oct 24, 2026. Sources: SAM.gov and Grants.gov. Snapshot govcon-directory-20261024T104923Z-2151694.
This product uses the Grants.gov API but is not endorsed or certified by the U.S. Department of Health and Human Services. Counts and totals are computed by DSE from public SAM.gov and Grants.gov notices. Text from Grants.gov may be shortened or have contact details removed. The original notice on Grants.gov is the authoritative version.
Closing in 109 days
Notice details
- Sub-tier agency
- NATIONAL INSTITUTES OF HEALTH
- Notice type
- Solicitation
- Solicitation number
- ARPA-H-SOL-26-150
- Product/service code
- AN41
- Place of performance
- District of Columbia
- Posted
- Oct 23, 2026
- Response deadline
- Feb 10, 2027
- Source
- SAM.gov
Description
The Advanced Research Projects Agency for Health (ARPA-H) Emerging Health Innovators (EHI) aims to or seeks to ensure ARPA-H identifies and engages early career investigators. To achieve this goal, ARPA-H is soliciting proposals from these researchers and innovators and their organizations to develop cutting-edge biomedical, health, and community-engaged research and innovation. ARPA-H anticipates multiple Other Transaction awards resulting from this announcement Amendment 1: This amendment clarifies the number of submissions that may be submitted by each offeror. See section 2.4 of the ISO. It also updates the solution summary cover sheet and the FAQ. Amendment 2: This amendment uploads two question and answer documents.
Summarized from the official notice.
Official notice
Requirements and amendments are controlled by the official notice.
DSE verdict
The DSE fit verdict for this notice is available to DSE GovCon subscribers. It is not published on this page.
See DSE GovCon plans →Similar open notices
- Quantitative Analysis of Longitudinal MR ImagesClosing in 16 days
- Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & ResponseClosing in 27 days
- Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)Closing in 37 days
- Pre-Clinical Models of Infectious DiseasesClosing in 44 days
- UNifying Imaging with QUantum Entanglement (UNIQUE) Innovative Solutions Opening (ISO)Closing in 53 days
Get free alerts
Email alerts for notices like this one are free on DSE GovCon Intelligence.
Set up free alerts →Frequently asked questions
When is the response deadline?
The published deadline is Feb 10, 2027. That is 109 days after the data date.
What NAICS code applies?
NAICS 541714, Research and Development in Biotechnology (except Nanobiotechnology).
Which agency issued this notice?
Department of Health and Human Services.
Where is the official notice?
The link under Official notice opens the source listing.